Equity Research Analyst – Healthcare
Il y a 2 jours
Brussels, Brussels-Capital, Belgique
Keystone Group
Temps plein
Gratuit avec email ou Google
Enregistrez cette offre et organisez votre recherche
Créez un compte gratuit pour enregistrer des offres d'emploi, créer des alertes et revenir à cette liste depuis votre tableau de bord.
Gratuit avec email ou Google
En continuant, vous acceptez nos Conditions d’utilisation & Politique de confidentialité.
Role Overview
We are seeking a Medical Doctor (MD)—specifically a physician with deep ties to Thailand and the broader ASEAN healthcare ecosystem—to join our Hong Kong-based family office as an Equity Research Analyst – Healthcare.
Operating with permanent, patient capital and a multi-year investment horizon, our family office invests across global public equities (US, HKEX/China, Europe, Asia-Pacific) and select late-stage private healthcare companies. You will bridge clinical medicine and institutional capital allocation—translating scientific rigor, real-world clinical judgment, and regional ASEAN market insights into high-conviction investment theses for the Principal and Investment Committee.
We actively welcome practicing or former clinicians who can demonstrate strong quantitative aptitude, financial literacy, and a passion for public and private markets
Key Responsibilities
Clinical & Scientific Due Diligence: Evaluate clinical trial designs, statistical endpoints, mechanism-of-action (MoA) differentiation, safety/tolerability profiles, and regulatory pathways (US FDA, EMA, NMPA, and ASEAN regulators) across global therapeutics, medtech, and diagnostics companies. ASEAN & Thailand Healthcare Coverage: Leverage on-the-ground networks across Thailand and Southeast Asia to track regional hospital operators, medical tourism trends, pharmaceutical distribution, specialty clinics, and cross-border expansion opportunities. Primary Research & KOL Engagement: Conduct peer-to-peer diligence with Key Opinion Leaders (KOLs), specialist physicians, hospital procurement heads, and C-suite executives at global medical conferences (e.g., ASCO, ESMO, AHA) and across Asia. Financial Modeling & Valuation: Build and maintain three-statement financial models, probability-adjusted Net Present Value (rNPV) drug/device pipeline models, sum-of-the-parts (SOTP) analyses, and DCF valuations (full training and mentorship provided for candidates transitioning directly from clinical practice). Investment Memos & IC Presentations: Author concise, thesis-driven investment memos detailing bull/bear scenarios, key clinical/commercial catalysts, variant perceptions, and downside risks; present recommendations directly to the CIO and Investment Committee. Private & Crossover Deal Evaluation: Partner with the private investments team to assess regional healthcare co-investments, pre-IPO rounds, and strategic partnerships between global biotechs and Asian healthcare providers. Qualifications & Experience
• Medical Credentials: Doctor of Medicine (MD) from a leading Thai or international medical school (e.g., Chulalongkorn, Mahidol/Siriraj/Ramathibodi, Chiang Mai, or accredited overseas institutions). Clinical residency, specialty training, or hospital practice experience is highly valued.
• Investment & Analytical Background: 2–5+ years of experience in clinical practice, healthcare consulting, venture capital, equity research, or healthcare corporate development Regional & Language Fluency:
• Native or full professional fluency in Thai and business-level fluency in English (essential for reading clinical literature, financial filings, and writing investment memos).
• Deep familiarity with Thailand’s public/private healthcare landscape, medical tourism dynamics, and ASEAN payer/reimbursement structures. Core Competencies & Mindset:
• Commercial Skepticism: Ability to distinguish between an impressive academic clinical result and a commercially viable product that doctors will actually prescribe or adopt.
• Quantitative Comfort: Strong analytical rigor and proficiency in Excel
• High Discretion & Long-Term Focus: Integrity, intellectual honesty, and discretion suited for a private family office environment.
Key Responsibilities
Clinical & Scientific Due Diligence: Evaluate clinical trial designs, statistical endpoints, mechanism-of-action (MoA) differentiation, safety/tolerability profiles, and regulatory pathways (US FDA, EMA, NMPA, and ASEAN regulators) across global therapeutics, medtech, and diagnostics companies. ASEAN & Thailand Healthcare Coverage: Leverage on-the-ground networks across Thailand and Southeast Asia to track regional hospital operators, medical tourism trends, pharmaceutical distribution, specialty clinics, and cross-border expansion opportunities. Primary Research & KOL Engagement: Conduct peer-to-peer diligence with Key Opinion Leaders (KOLs), specialist physicians, hospital procurement heads, and C-suite executives at global medical conferences (e.g., ASCO, ESMO, AHA) and across Asia. Financial Modeling & Valuation: Build and maintain three-statement financial models, probability-adjusted Net Present Value (rNPV) drug/device pipeline models, sum-of-the-parts (SOTP) analyses, and DCF valuations (full training and mentorship provided for candidates transitioning directly from clinical practice). Investment Memos & IC Presentations: Author concise, thesis-driven investment memos detailing bull/bear scenarios, key clinical/commercial catalysts, variant perceptions, and downside risks; present recommendations directly to the CIO and Investment Committee. Private & Crossover Deal Evaluation: Partner with the private investments team to assess regional healthcare co-investments, pre-IPO rounds, and strategic partnerships between global biotechs and Asian healthcare providers. Qualifications & Experience
• Medical Credentials: Doctor of Medicine (MD) from a leading Thai or international medical school (e.g., Chulalongkorn, Mahidol/Siriraj/Ramathibodi, Chiang Mai, or accredited overseas institutions). Clinical residency, specialty training, or hospital practice experience is highly valued.
• Investment & Analytical Background: 2–5+ years of experience in clinical practice, healthcare consulting, venture capital, equity research, or healthcare corporate development Regional & Language Fluency:
• Native or full professional fluency in Thai and business-level fluency in English (essential for reading clinical literature, financial filings, and writing investment memos).
• Deep familiarity with Thailand’s public/private healthcare landscape, medical tourism dynamics, and ASEAN payer/reimbursement structures. Core Competencies & Mindset:
• Commercial Skepticism: Ability to distinguish between an impressive academic clinical result and a commercially viable product that doctors will actually prescribe or adopt.
• Quantitative Comfort: Strong analytical rigor and proficiency in Excel
• High Discretion & Long-Term Focus: Integrity, intellectual honesty, and discretion suited for a private family office environment.